eCential Robotics and ChoiceSpine Announce Long-Term Partnership to Enhance Robotic Spine Implant Surgery

2022-07-02 03:31:58 By : Ms. Cassie Zhang

GIÈRES, GRENOBLE, France & KNOXVILLE, Tenn., June 21, 2022--(BUSINESS WIRE)--eCential Robotics, a French growth company that designs, manufactures, and markets the first unified 2D/3D robotic imaging and surgical navigation system for bone surgery indications and ChoiceSpine LLC, a US privately-held spinal implant company, announced today their long-term partnership to offer a common optimized solution. This system combines navigation, robotics, and implant systems that are easy to use, accurate for spine surgeons, and benefits the patient.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220621005387/en/

Combining innovative technologies and strengths

After starting the process in 2021, eCential Robotics and ChoiceSpine agreed to partner their technologies with spine robotic surgeries. Built on the technical excellence of the products and a common long-term vision, a collaboration combining two critical assets is emerging:

The eCential Robotics platform pulls together intraoperative 2D/3D imaging, navigation, and robotics in its core design as the only available fully-unified, single-device solution with a single-user interface. In addition, the eCential Robotics platform is an open solution, catering to different surgeons' preferences. Built around a range of applications ("Apps") currently dedicated to spine surgery, there are plans for multiple bone surgery indications soon.

ChoiceSpine is a spinal implant company with a robust, comprehensive hardware and orthobiologics portfolio. The Knoxville-based company is recognized for introducing innovative and niche solutions to the spinal implant market, emphasizing MIS solutions, such as the Thunderbolt™ Minimally Invasive Pedicle Screw System and the Triton™ 3D printed SI Joint Fixation System. Other differentiating technologies offered by ChoiceSpine include proprietary BioBond™ 3D printed interbodies, a shallow docking access system for direct lateral surgery, and multiple cervical fusion options. In addition, the orthobiologics portfolio offers bone graft solutions, including 100% demineralized bone matrix, cortical fibers, synthetics, a cellular bone matrix, structural allograft, and allograft sponge options.

Taking full advantage of ChoiceSpine implant solutions using eCential Robotics' unified platform

Navigation and robotics will make it possible to fully utilize the specific features of ChoiceSpine's portfolio and offer optimization of the surgical procedure. It also brings spine surgeons and patients the benefits of the latest advances in navigation, robotics, and implant technologies.

"By enabling eCential Robotics' platform to navigate ChoiceSpine implants with our robotic arm, we will optimize and add value to our unified and universal solution for the benefit of surgeons and patients," said Mrs. Laurence Chabanas, eCential Robotics Chief Strategy Officer. "This partnership is a part of eCential Robotics' open model strategy. Since our ambition is to offer a unique platform for bone surgery in the operating room and become a standard, we are open to collaborating with implant companies to combine our technologies and offer optimized navigation and robotics for the implementation proposed to the patient," she added.

Steve Ainsworth, PhD, ChoiceSpine's EVP of Strategy and Technology, said:

"This combination of our innovative cultures will allow us to expand our clinical value by fully encompassing the surgical experience. We believe the eCential Robotics platform, in conjunction with our comprehensive spinal implant and orthobiologics portfolios, will lead the way in advancing spine surgery. This partnership is just one example of how ChoiceSpine brings technically superior spinal devices to the market and is doing spine the right way."

Initiate eCential Robotics penetration of the US market

After receiving FDA 510(k) clearance of its unified platform's 2D/3D robotic imaging technology in 2021, eCential Robotics has conducted pre-clinical evaluation tests in the USA, in Q1 2022, with neurosurgeons and orthopedic surgeons. In addition, it has launched the process to obtain clearance for its navigation and collaborative robot (CoBot) device. To support the penetration of the North American market, an eCential Robotics, Inc. subsidiary was created in December 2020.

"This close cooperation with a US company provides eCential Robotics with access to complementary technologies and allows us to initiate and expand our footprint in the US market," declared Mrs. Laurence Chabanas, eCential Robotics Chief Strategy Officer.

eCential Robotics is a Grenoble-based company specializing in surgical robotics. It develops and markets a unique system unifying 2D/3D robotic imaging and real-time navigation. With 80 patents and seven trademarks, it pursues a disruptive innovation strategy. It offers orthopedic and neurosurgeons easy-to-use, cutting-edge technology to visualize their operations, particularly minimally invasive surgery. The eCential Robotics platform is a universal system open to all implants.

Winner of the Bpifrance Worldwide Innovation Challenge in 2018, the company designs and produces all its equipment in Grenoble, France. Please visit www.ecential-robotics.com and follow us on LinkedIn (eCential Robotics) and Twitter (@ecentialrobot).

ChoiceSpine LLC is a spinal device company located in Knoxville, TN, privately held by Altus Capital Partners. ChoiceSpine prides itself on providing excellent products aimed at improving people's lives through a positive customer experience. Here at ChoiceSpine, we offer a variety of surgeon-focused product lines designed to be safe, efficient, and easy to use. By focusing on a collaborative team approach with physicians and industry partners, ChoiceSpine continues to deliver upon product commitments, maintain cutting-edge research and development, and bring technically superior products to the forefront of the spinal implant industry. For more information, please visit www.choicespine.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220621005387/en/

eCential Robotics: Media contact Marie CABRIÈRES marie.cabrieres@ecential-robotics.com +33 6 07 27 19 86

Investor relations Benjamin COLAS benjamin.colas@ecential-robotics.com +33 7 85 58 35 14

ChoiceSpine: Media contact Ron Moore Sr. Director of Marketing 865-246-3333 rmoore@choicespine.com

Shares of Nvidia (NASDAQ: NVDA) plunged this week after the company's stock received a price target cut, some analysts had a few negative comments about the chip market, and investors worried that comments made from another chip company about slowing demand might mean bad news for Nvidia as well. Investors panicked a bit on all this news and sent the semiconductor stock falling 15.3% over the past week. Nvidia started off the week with Morgan Stanley warning that there could be a potential slowdown in demand for graphics processors as Ethereum, a leading blockchain and cryptocurrency, switches to a proof-of-stake model and away from its current proof-of-work setup.

The Oracle of Omaha knows how to beat inflation. So ride his coattails.

The super investor still sees opportunities ahead.

Oppenheimer continues to expect strong fundamentals in the U.S. banking sector, even as fears of a recession heighten.

Last late-week rally in the markets quickly faded and this week is ending with declines in the major stock indexes. It’s the classic patter on the dead cat bounce, a brief recovery that is followed by more losses, and it has investors worried that there is no bottom in sight. Writing from the global markets strategy team, where he takes a broader look at the worldwide market situation, JPMorgan’s Marko Kolanovic lays out the headwinds running against US investors: “First and foremost, an unprece

The leading gene editing company CRISPR Therapeutics is looking better to technically oriented traders. Let's take a look. In this daily bar chart of CRSP, below, we can see that following a downtrend that prices have turned sideways since January.

As the painful first half of 2022 ends, many income investors are hoping for some sort of relief. Many dividend stocks have seen their yields creep subtly higher in recent months as their share prices slowly trended lower. For income investors, the current environment has been quite hostile to dip-buyers. We've suffered quite a few short-lived bear market bounces this year. Many more are sure to follow. Though the likelihood of a V-shaped recovery is diminishing with every swift move lower, ther

Canadian crypto broker Voyager Digital is suspending trading including deposits and withdrawals according to a statement released by the firm Friday afternoon.

A bear market leaves the S&P 500 with its worst first six months since 1970. Here's what's happened after stocks suffered steep first-half stumbles in the past.

GM said chip shortages and supply chain snarls left nearly 100,000 vehicles unfinished over the second quarter.

If there’s one common theme connecting the market’s experts, it’s ‘be a contrarian.’ Don’t follow the herd, focus on underlying facts, and don’t be afraid to throw out the conventional wisdom. Or, in a memorable phrase from Warren Buffett, “Be fearful when others are greedy, and greedy when others are fearful.” Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program has always had a talent for swimming against the stream, and he has not shied away from pointing out the stocks that investor

Now that Q2 has come to end, the focus on Wall Street will turn to the second quarter results. In Apple’s (AAPL) case, the past 3 months have been defined by the Covid lockdowns in China which will adversely affect revenue by between $4 billion and $8 billion. However, recent checks made by Wedbush analyst Daniel Ives regarding the Asia iPhone supply chain indicate that over the past few weeks the situation has been “steady with slight improvements.” “As of now we believe iPhone demand is holdin

Bitcoin resumed its slide this week and the crypto winter is getting colder. More crypto funds and lenders are on the edge, while the stock market woes have weighed on Bitcoin and other cryptocurrencies, which have traded like speculative growth stocks. Bitcoin failed to hang onto $21,000 at the start of the week and briefly tumbled as low as $18,650 late Thursday.

Yahoo Finance crypto reporter David Hollerith breaks down FTX's deal with BlockFi, in addition to Voyager Digital's stock trading halt.

The uncertain macro environment demands constant reassessment around companies’ anticipated performance. Coming off the back of J.P. Morgan’s recent Energy, Power and Renewables Conference, firm analyst Bill Peterson notes that Plug Power’s (PLUG) management continues to see “significant seasonality” in the material handling and electrolyzer businesses. This will nudge sales to the back half of the year and will result in a 35% - 65% split between 1H and 2H, which is “more back half-weighted” th

Yahoo Finance's Allie Garfinkle discusses Meta's vulnerability to an economic downturn and CEO Mark Zuckerberg's latest comments on running the tech company.

Shares of Shopify (NYSE: SHOP) plummeted 18.2% this week on several bits of news. First, shares fell earlier in the week when revised GDP figures were released, showing that the economy was slowing down slightly more than expected. Additionally, a new report released yesterday, showing that inflation remains stubbornly high despite the Federal Reserve's efforts to bring it down, is likely weighing down on the stock this week.

The current market conditions – the NASDAQ is down 29% year-to-date, and the S&P 500 is down 21% – offer bargain hunters a target-rich environment. Plenty of sound stocks have seen their prices decline, pulled down by the general market headwinds and the overall stock trend, to levels that have left them too cheap to ignore. At this level, investors can find the benefits of cheap stocks, which offer both learning opportunities and strong upside potential. However, in evaluating stocks to buy, it

Few investors have a nose for making money quite like billionaire Warren Buffett. Since becoming CEO of conglomerate Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965, the Oracle of Omaha, as he's come to be known, has created more than $610 billion in value for shareholders and delivered an aggregate return on his company's Class A shares (BRK.A) of 3,641,613%, through Dec. 31, 2021. As we push into the second half of what's been an exceptionally volatile and challenging year for investors, several Berkshire Hathaway holdings stand out as amazing values.

Michael Burry called the stock market the “greatest speculative bubble of all time in all things” last year. Now, he’s arguing corporate earnings will take a hit, driving prices even lower.